Clinical Study on the Safety of Double and a Half Layered Esophagojejunal Anastomosis in Curative Gastrectomy
Surgery--Complications

About this trial
This is an interventional treatment trial for Surgery--Complications focused on measuring Gastricneoplasms, gastrectomy, Esophagojejunal anastomosis, Complications
Eligibility Criteria
Inclusion Criteria:
- The patients voluntarily participated in the study and signed the informed consent
- 18 years old≤75 years old
- The primary gastric lesion was diagnosed as gastric adenocarcinoma by endoscopic biopsy
- Patients scheduled for radical gastrectomy with esophagojejunostomy (also applicable for multiple primary cancers)
- ECOG physical status score 0/1
- ASA score I-III
- The expected survival time is more than 12 weeks
- The patient agreed to accept the operation and signed the informed consent form to undertake the risk of the operation
Exclusion Criteria:
- Other malignant tumors occurred or coexisted within 5 years
- History of upper abdominal surgery (except laparoscopic cholecystectomy)
- History of gastric surgery (except for patients who failed ESD/EMR for gastric cancer and needed radical gastrectomy and planned esophagojejunostomy)
- Pregnant or lactating women
- Have a history of psychotropic drug abuse and can not quit or have mental disorders
- Patients with severe cachexia, inability to eat or tolerate surgery
- Preoperative imaging examination showed that the tumor invaded the surrounding organs and regional fusion enlarged lymph nodes (maximum diameter≥3cm) and could not be radical resection
- A history of unstable angina or myocardial infarction within 6 months There was a history of cerebral infarction or cerebral hemorrhage within 6 months
- There was a history of continuous systemic corticosteroid therapy within 1 month
- Other diseases need to be treated by surgery at the same time
- Gastric cancer complications (bleeding, perforation, obstruction) need emergency surgery
- Pulmonary function test FEV1<50% of predicted value
Patients with any severe and/or uncontrolled disease include:
- Patients with hypertension who can not be well controlled by antihypertensive drugs (systolic blood pressure≥150 mmHg, diastolic blood pressure≥100 mmHg);
- Patients with grade I or above myocardial ischemia or myocardial infarction, arrhythmia (including QTc≥480ms) and grade 2 or above congestive heart failure (NYHA classification);
- Active or uncontrolled severe infection (≥CTCAE grade 2 infection);
- Renal failure requires hemodialysis or peritoneal dialysis;
- History of immunodeficiency, including HIV positive or other acquired or congenital immunodeficiency diseases, or organ transplantation;
- The patients with poor glycemic control (FBG>10mmol/L);
- Patients with epilepsy and need treatment;
- According to the judgment of the researchers, there are concomitant diseases that seriously endanger the safety of patients or affect the completion of the study
Sites / Locations
- Henan cancer hopitalRecruiting
Arms of the Study
Arm 1
Other
The safety of esophagojejunostomy in total gastrectomy for gastric cancer
The safety of esophagojejunostomy depends on the integrity of the anastomosis, sufficient blood supply and satisfactory tension. Early tight mucosal anastomosis and the proliferation of mucosal epithelial cells can reduce the stimulation of digestive fluid to the anastomotic wound.Professor Zhao Yuzhou surgical team proposed double and a half layered esophagojejunal anastomosis to improve the safety of anastomosis. This method is simple and has no special requirements for the selection of instruments and sutures. It can be carried out in all levels of hospitals. In order to verify the value of this method in gastrointestinal reconstruction of gastric cancer, Professor Zhao Yuzhou surgical team plans to carry out a multicenter, randomized controlled study throughout the province.